Logo image of BCAL

CALIFORNIA BANCORP (BCAL) Stock Fundamental Analysis

USA - NASDAQ:BCAL - US84252A1060 - Common Stock

18.49 USD
+0.27 (+1.48%)
Last: 10/31/2025, 8:27:54 PM
18.49 USD
0 (0%)
After Hours: 10/31/2025, 8:27:54 PM
Fundamental Rating

5

Overall BCAL gets a fundamental rating of 5 out of 10. We evaluated BCAL against 390 industry peers in the Banks industry. While BCAL is still in line with the averages on profitability rating, there are concerns on its financial health. BCAL is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BCAL was profitable.
BCAL had a positive operating cash flow in the past year.
BCAL Yearly Net Income VS EBIT VS OCF VS FCFBCAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

BCAL has a Return On Assets (0.79%) which is comparable to the rest of the industry.
The Return On Equity of BCAL (5.71%) is worse than 72.05% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.17%, BCAL belongs to the top of the industry, outperforming 99.49% of the companies in the same industry.
BCAL had an Average Return On Invested Capital over the past 3 years of 1.52%. This is in line with the industry average of 2.46%.
The last Return On Invested Capital (2.17%) for BCAL is above the 3 year average (1.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROIC 2.17%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
BCAL Yearly ROA, ROE, ROICBCAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2 4 6 8

1.3 Margins

BCAL has a Profit Margin of 13.66%. This is in the lower half of the industry: BCAL underperforms 77.69% of its industry peers.
BCAL's Profit Margin has declined in the last couple of years.
BCAL has a Operating Margin of 54.68%. This is amongst the best in the industry. BCAL outperforms 99.74% of its industry peers.
In the last couple of years the Operating Margin of BCAL has grown nicely.
Industry RankSector Rank
OM 54.68%
PM (TTM) 13.66%
GM N/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BCAL Yearly Profit, Operating, Gross MarginsBCAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

BCAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BCAL has been increased compared to 1 year ago.
BCAL has a better debt/assets ratio than last year.
BCAL Yearly Shares OutstandingBCAL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
BCAL Yearly Total Debt VS Total AssetsBCAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -0.68, we must say that BCAL is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of -0.68, BCAL belongs to the best of the industry, outperforming 98.97% of the companies in the same industry.
The Debt to FCF ratio of BCAL is 54.39, which is on the high side as it means it would take BCAL, 54.39 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 54.39, BCAL is doing worse than 84.10% of the companies in the same industry.
BCAL has a Debt/Equity ratio of 6.15. This is a high value indicating a heavy dependency on external financing.
BCAL has a Debt to Equity ratio of 6.15. This is amonst the worse of the industry: BCAL underperforms 96.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Altman-Z -0.68
ROIC/WACC0.56
WACC3.87%
BCAL Yearly LT Debt VS Equity VS FCFBCAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.3 Liquidity

BCAL has a Current Ratio of 0.04. This is a bad value and indicates that BCAL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BCAL (0.04) is better than 99.23% of its industry peers.
A Quick Ratio of 0.04 indicates that BCAL may have some problems paying its short term obligations.
BCAL has a better Quick ratio (0.04) than 99.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
BCAL Yearly Current Assets VS Current LiabilitesBCAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1B 2B 3B

8

3. Growth

3.1 Past

BCAL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.95%, which is quite impressive.
The earnings per share for BCAL have been decreasing by -28.36% on average. This is quite bad
BCAL shows a strong growth in Revenue. In the last year, the Revenue has grown by 80.83%.
The Revenue has been growing by 37.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)63.95%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%4200%
Revenue 1Y (TTM)80.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%99.64%

3.2 Future

BCAL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.60% yearly.
BCAL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.07% yearly.
EPS Next Y141.4%
EPS Next 2Y48.44%
EPS Next 3Y31.6%
EPS Next 5YN/A
Revenue Next Year36.74%
Revenue Next 2Y18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BCAL Yearly Revenue VS EstimatesBCAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 50M 100M 150M
BCAL Yearly EPS VS EstimatesBCAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.11, the valuation of BCAL can be described as correct.
BCAL's Price/Earnings is on the same level as the industry average.
BCAL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.10.
A Price/Forward Earnings ratio of 11.49 indicates a reasonable valuation of BCAL.
Based on the Price/Forward Earnings ratio, BCAL is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
BCAL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.52, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.11
Fwd PE 11.49
BCAL Price Earnings VS Forward Price EarningsBCAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BCAL indicates a rather cheap valuation: BCAL is cheaper than 99.74% of the companies listed in the same industry.
BCAL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BCAL is cheaper than 69.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.72
EV/EBITDA 4.29
BCAL Per share dataBCAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BCAL's earnings are expected to grow with 31.60% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y48.44%
EPS Next 3Y31.6%

0

5. Dividend

5.1 Amount

No dividends for BCAL!.
Industry RankSector Rank
Dividend Yield N/A

CALIFORNIA BANCORP

NASDAQ:BCAL (10/31/2025, 8:27:54 PM)

After market: 18.49 0 (0%)

18.49

+0.27 (+1.48%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-27 2025-10-27/bmo
Earnings (Next)01-27 2026-01-27/bmo
Inst Owners57.67%
Inst Owner Change0.02%
Ins Owners24.1%
Ins Owner Change-0.28%
Market Cap601.29M
Revenue(TTM)228.79M
Net Income(TTM)31.26M
Analysts80
Price Target19.38 (4.81%)
Short Float %1.55%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.56%
Min EPS beat(2)3.66%
Max EPS beat(2)27.45%
EPS beat(4)4
Avg EPS beat(4)33.05%
Min EPS beat(4)3.66%
Max EPS beat(4)87.43%
EPS beat(8)4
Avg EPS beat(8)0.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.08%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-4.17%
Min Revenue beat(4)-8.89%
Max Revenue beat(4)-2.03%
Revenue beat(8)0
Avg Revenue beat(8)-4.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.42%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)0.04%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)-2.94%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-1.9%
Valuation
Industry RankSector Rank
PE 13.11
Fwd PE 11.49
P/S 2.63
P/FCF 9.72
P/OCF 9.65
P/B 1.1
P/tB 1.44
EV/EBITDA 4.29
EPS(TTM)1.41
EY7.63%
EPS(NY)1.61
Fwd EY8.7%
FCF(TTM)1.9
FCFY10.29%
OCF(TTM)1.92
OCFY10.37%
SpS7.04
BVpS16.84
TBVpS12.8
PEG (NY)0.09
PEG (5Y)N/A
Graham Number23.11
Profitability
Industry RankSector Rank
ROA 0.79%
ROE 5.71%
ROCE 20.83%
ROIC 2.17%
ROICexc 2.22%
ROICexgc 2.34%
OM 54.68%
PM (TTM) 13.66%
GM N/A
FCFM 27.04%
ROA(3y)0.65%
ROA(5y)N/A
ROE(3y)5.41%
ROE(5y)N/A
ROIC(3y)1.52%
ROIC(5y)N/A
ROICexc(3y)1.54%
ROICexc(5y)N/A
ROICexgc(3y)1.61%
ROICexgc(5y)N/A
ROCE(3y)15.77%
ROCE(5y)N/A
ROICexgc growth 3Y37.36%
ROICexgc growth 5YN/A
ROICexc growth 3Y36.52%
ROICexc growth 5YN/A
OM growth 3Y19.95%
OM growth 5YN/A
PM growth 3Y-42.04%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 6.15
Debt/FCF 54.39
Debt/EBITDA 25.73
Cap/Depr 8.18%
Cap/Sales 0.2%
Interest Coverage 2.01
Cash Conversion 47.67%
Profit Quality 197.92%
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z -0.68
F-Score8
WACC3.87%
ROIC/WACC0.56
Cap/Depr(3y)28.31%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.57%
Cap/Sales(5y)N/A
Profit Quality(3y)372.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.95%
EPS 3Y-28.36%
EPS 5YN/A
EPS Q2Q%4200%
EPS Next Y141.4%
EPS Next 2Y48.44%
EPS Next 3Y31.6%
EPS Next 5YN/A
Revenue 1Y (TTM)80.83%
Revenue growth 3Y37.61%
Revenue growth 5YN/A
Sales Q2Q%99.64%
Revenue Next Year36.74%
Revenue Next 2Y18.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.16%
EBIT growth 3Y65.06%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.29%
FCF growth 3Y40.59%
FCF growth 5YN/A
OCF growth 1Y59.14%
OCF growth 3Y36.79%
OCF growth 5YN/A

CALIFORNIA BANCORP / BCAL FAQ

Can you provide the ChartMill fundamental rating for CALIFORNIA BANCORP?

ChartMill assigns a fundamental rating of 5 / 10 to BCAL.


Can you provide the valuation status for CALIFORNIA BANCORP?

ChartMill assigns a valuation rating of 6 / 10 to CALIFORNIA BANCORP (BCAL). This can be considered as Fairly Valued.


Can you provide the profitability details for CALIFORNIA BANCORP?

CALIFORNIA BANCORP (BCAL) has a profitability rating of 4 / 10.


What is the valuation of CALIFORNIA BANCORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CALIFORNIA BANCORP (BCAL) is 13.11 and the Price/Book (PB) ratio is 1.1.